Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 27, 2001

View Archived Issues

PDL grants license to Celltech for humanized anti-TNF antibodies

Xenon Genetics discovers two new drug targets for metabolic and neurological diseases

Worldwide expansion of Merck/Schering-Plough cholesterol partnership

Asimadoline alters cytokine gene expression in adjuvant arthritis

TAS-108 well tolerated and readily absorbed after oral dosing in preliminary clinical trial

CS-758: a new triazole antifungal agent with promise for candidiasis and aspergillosis

SkyePharma withdraws Solaraze termination notice

Cytovax files for approval to begin human trials of Cytovaxine

Clarinex cleared by FDA for SAR symptom relief, will be launched next month

New option for early-stage prostate cancer receives FDA clearance

Thalomid granted orphan drug status in Europe for multiple myeloma and ENL

Orally active growth hormone secretagogue SM-130686 identified by Sumitomo

Amgen initiates phase III AMG-073 trial for hyperparathyroidism

IL-12 gene therapy studied in Japan for inducing tumor immunity

Phase I trial initiated for antithrombotic drug candidate GH-9001

GSK discontinues development of ADL-2-1294

Potent new MMP inhibitor has excellent oral activity in a rat collagen degradation model

Forest submits NDA for oxycodone/ibuprofen to treat moderate to severe pain

Myriad Genetics seeks clearance for new clinical trial of Flurizan

Companies collaborate in developing neuroprotective compound DD-612

Superior efficacy of triple-antigen hepatitis B vaccine confirmed in inadequate responders

Avigen receives FDA approval to continue clinical trials for Coagulin-B gene therapy

New series from Bayer with excellent antiallergic activity

Lipase inhibitors produced by Streptomyces

CRF antagonists from a series of tricyclic fused pyrimidine and pyridine derivatives

Korean researchers identify new CDK inhibitors

Boston-based scientists disclose radiolabeled tumor imaging agents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...